Posted On: 08/06/2014 9:22:33 AM
Post# of 7841
Re: Roger Wilco #205
GNSZ News interview with Dr. Craig Dionne, PhD, GenSpera CEO
GenSpera's CEO Shares Insight on Unique Properties and Targeting of Lead Drug G-202, Based on the Thapsigargin Toxin
http://finance.yahoo.com/news/gensperas-ceo-s...00390.html
POINT ROBERTS, Wash. and NEW YORK, Aug. 5, 2014 /PRNewswire/
GenSpera's CEO Shares Insight on Unique Properties and Targeting of Lead Drug G-202, Based on the Thapsigargin Toxin
http://finance.yahoo.com/news/gensperas-ceo-s...00390.html
POINT ROBERTS, Wash. and NEW YORK, Aug. 5, 2014 /PRNewswire/
(0)
(0)Scroll down for more posts ▼
